All epidemiological studies are bedevilled by the problem of undetected cases and this is especially so in inflammatory bowel disease, where all previous studies have been based on patients diagnosed in hospital. In Nottingham the existence of a screening programme for colorectal cancer provided an opportunity for apparently asymptomatic cases of inflammatory bowel disease to be identified and their prevalence in the population to be assessed. The prevalence of these two cases who were lost to follow up for more than 20 years was 11 2/10 (95% confidence interval 0-44.6/10). Eight patients with inflammatory bowel disease were identified during a screening programme for colorectal cancer.
Method
The prevalence of previously undiagnosed ulcerative colitis in this population aged between 50 and 75 years was at least 33.5/10s (Table 3) . It is likely that this is an underestimate as it is improbable that all cases were detected by the FOB test. If the two patients lost to follow up were included as well as the asymptomatic cases the prevalence rose to 44.6/10( 95% confidence interval 22-3-89-2). The prevalence of asymptomatic Crohn's disease was 11-2/10, a third of that reported for symptomatic Crohn's disease from other centres.
Discussion
The true prevalence of any disease state is difficult to determine. This is the first study to identify previously undiagnosed asymptomatic cases of inflammatory bowel disease in the community. This has only been possible because of the existence of a large population screening study for the detection of colorectal neoplasia using FOBT. Most studies suggest that the combined prevalence of symptomatic ulcerative colitis and Crohn's disease lies between 90/101 and 150/10'. In 1980 Devlin et al' in a study from North Tees, England reported the com- (Table 4 ) compared with 33-5I10 asymptomatic cases reported in this study. The prevalence of Crohn's disease is between 35 and 56/10( ( Table 4 ) and data from Cardiff suggest that the prevalence in those aged 50 to 75 years is about 48/I10. The prevalence of asymptomatic Crohn's disease in this study was 11 -2/ 10 . It seems likely that studies which are based on symptomatic patients diagnosed in hospital may underestimate the true prevalence of inflammatory bowel disease by between 27% and 38%. Such findings are of considerable importance to our understanding of the epidemiology of these diseases.
It is unlikely that the increase in incidence that has recently been reported in many countries2' is the result of increased detection of apparently asymptomatic patients. It is interesting that even on direct questioning most of the patients identified in this study denied symptoms of inflammatory bowel disease, despite the extent of their disease. The only two patients who admitted to any gastrointestinal symptoms considered them minimal and of no consequence.
In seven of the eight patients with ulcerative colitis there was total involvement of the colon. This identification of a high proportion of patients with total colitis and only one case of proctitis may be a reflection of the technique used to detect blood loss rather than a true reflection of the pattern of asymptomatic disease in the community. The modified guaiac test relies on the presence of haemolysed blood in faeces to produce a positive result. Previous studies using this technique have suggested that its ability to detect bleeding rectal cancers is less than colonic cancers. Blood shed into the rectum may be insufficiently haemolysed, less uniformly mixed with facces and so produce a false negative result.' This could explain our failure to identify more than one patient with proctitis.
This study highlights concern about the accuracy and completeness of case detection of inflammatory bowel disease. The existence of unrecognised cases of inflammatory bowel disease especially ulcerative colitis is of particular concern in view of the premalignant nature of this disease. It suggests that further study should be directed towards the early identification of such patients. 
